The BET inhibitor mCRPC papers keep piling up

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

The BET inhibitor mCRPC papers keep piling up

posted on Mar 21, 2018 11:33AM

Add another paper to the stack of studies showing the potential of BET inhibitors in mCRPC.

Targeting bromodomain and extra-terminal (BET) family proteins in castration resistant prostate cancer (CRPC).

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply